Residual paralysis after cancer surgery in frail patients
Part of Brain & nervous system, Cancer, Women’s health & pregnancy clinical trials.
This trial checks how often muscle relaxant effects linger after gynecologic cancer surgery, especially in frail patients. It uses a nerve stimulator to measure muscle function after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having scheduled surgery for gynecologic cancer
- You can communicate in Thai
- You can understand a questionnaire
- You do not have a muscle or nerve disease
- You do not have a wrist problem that could affect the nerve test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a device called TetraGraph to measure how quickly a muscle relaxant (rocuronium) works and wears off during surgery. It may help doctors better manage anesthesia for patients who need this medicine.
This study compares two ways to monitor muscle relaxation during surgery. It looks at how well a nerve monitor on the arm works versus one on the wrist, to help doctors give the right amount of muscle relaxant medicine.
This study compares two different monitors that measure how deeply your muscles are relaxed during long surgeries (over 3 hours) like laparoscopic, robotic, or chest surgeries. The monitors help the anesthesia team keep you safe and comfortable.
This trial compares two devices that measure how well muscle relaxant medicine is working during planned surgery. It may help anesthesiologists choose monitoring that improves safety by confirming the muscles are relaxing as intended.
This trial compares two places on the hand—the thumb base and the pinky base—to see which is better for monitoring muscle relaxation during surgery. Participants will have their muscle response measured with a gentle electrical test (electromyography) while receiving a standard muscle relaxant (rocuronium).
This study checks how well a risk score predicts muscle weakness after surgery. It uses a monitor to measure muscle recovery in the recovery room. If you are having elective surgery with muscle relaxants, this trial may help improve safety.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.